| Literature DB >> 16718933 |
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) infections are commonly treated with vancomycin (VAN) or another glycopeptide antibiotic. However, when vancomycin fails or infections recur, there are few other therapeutic options. Presented here are 2 cases where a novel combination of daptomycin, vancomycin, and rifampin resolved recurrent MRSA bone and prosthetic joint functions.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16718933 DOI: 10.1080/00365540500372697
Source DB: PubMed Journal: Scand J Infect Dis ISSN: 0036-5548